| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/03/2004 | WO2004046175A1 Vaccine |
| 06/03/2004 | WO2004046171A1 Novel functional peptide nucleic acid and process for producing the same |
| 06/03/2004 | WO2004046168A2 Recombinant hiv-1 subclass d envelope glycoproteins |
| 06/03/2004 | WO2004046167A2 Synthesis and self-assembly of abc triblock bola peptide |
| 06/03/2004 | WO2004046161A1 Novel 2’,5’-oligoadenylic acid analogues |
| 06/03/2004 | WO2004046160A2 Amino-lna, thio-lna and alpha-l-oxy-ln |
| 06/03/2004 | WO2004045602A1 Drug for inhibiting production of matrix metalloprotease-9 |
| 06/03/2004 | WO2004045553A2 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 06/03/2004 | WO2004045547A2 Rnai-based sensors, caged interfering rnas, and methods of use thereof |
| 06/03/2004 | WO2004045544A2 Autocrine growth factor receptor antibodies and methods |
| 06/03/2004 | WO2004045543A2 Functional and hyperfunctional sirna |
| 06/03/2004 | WO2004045530A2 Methods for treating, preventing, or reducing cardiac disorders using fadd inhibitors |
| 06/03/2004 | WO2004045527A2 Modulation of nima-related kinase 6 expression |
| 06/03/2004 | WO2004045517A2 Method for the diagnosis and treatment of vascular disease |
| 06/03/2004 | WO2004045516A2 Compositions and methods for the diagnosis and treatment of tumor |
| 06/03/2004 | WO2004045513A2 Coronary artery disease treatment |
| 06/03/2004 | WO2004045495A2 Interacting site for gp41 on gp120 of hiv-1 |
| 06/03/2004 | WO2004035615A3 Factor involved in metastasis and uses thereof |
| 06/03/2004 | WO2004031397A9 Detection of evolutionary bottlenecking by dna sequencing as a method to discover genes of value |
| 06/03/2004 | WO2004029252A3 A gene encoding vitamin b6 phosphate phosphatase and use thereof |
| 06/03/2004 | WO2004029215A9 Conditional gene expression using rnai |
| 06/03/2004 | WO2004029093A3 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 06/03/2004 | WO2004028562A3 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
| 06/03/2004 | WO2004027033A3 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/03/2004 | WO2004026903A3 Live antenuated parasite vaccine |
| 06/03/2004 | WO2004025416A3 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/03/2004 | WO2004024904A3 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/03/2004 | WO2004024769A3 Ostertagia vaccine |
| 06/03/2004 | WO2004024084A9 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 06/03/2004 | WO2004022708A3 Genes and proteins altering tau-related neurodegeneration |
| 06/03/2004 | WO2004020637A9 Flavonoid 3',5'hydroxylase gene sequences and uses therefor |
| 06/03/2004 | WO2004019879A3 Motilide compounds |
| 06/03/2004 | WO2004018515A3 T-cell epitopes in erythropoietin |
| 06/03/2004 | WO2004016786A3 Dna expression construct for multiple gene expression |
| 06/03/2004 | WO2004016283A3 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 06/03/2004 | WO2004015117A3 Targeted gene modification by single-stranded dna oligonucleotides |
| 06/03/2004 | WO2004013306A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 06/03/2004 | WO2004011648A3 CYTOCHROME P450s |
| 06/03/2004 | WO2004009021A3 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/03/2004 | WO2004007725A9 Polypeptide of streptococcus pyogenes |
| 06/03/2004 | WO2004007663A9 Gene expression using metal ion dependent repressor/operator tandems |
| 06/03/2004 | WO2004005522A3 Plasmid vectors for transformation of filamentous fungi |
| 06/03/2004 | WO2004005502A9 Programmed cell death used as a biological containment system |
| 06/03/2004 | WO2003106974A3 Diagnosis and treatment of chemoresistant tumors |
| 06/03/2004 | WO2003102183A9 Pramyxovirus vectors encoding antibody and utilization thereof |
| 06/03/2004 | WO2003100432A3 Method for identifying immunoreactive peptides |
| 06/03/2004 | WO2003099990A3 Compositions and methods for cloning nucleic acids |
| 06/03/2004 | WO2003099228A3 Compositions and processes for inhibiting gene expression using polynucleotides |
| 06/03/2004 | WO2003097796A3 T7 bacteriophage display of fabs |
| 06/03/2004 | WO2003095493A3 Toxin-related antibodies with antimicrobial and antiviral activity |
| 06/03/2004 | WO2003093476A9 Vector with modified protease-dependent tropism |
| 06/03/2004 | WO2003089580A3 Cancer models |
| 06/03/2004 | WO2003089475A3 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 06/03/2004 | WO2003089450A3 Fusion polypeptides and methods for inhibiting microbial adhesion |
| 06/03/2004 | WO2003088995A3 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 06/03/2004 | WO2003079025A3 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 06/03/2004 | WO2003072743A3 Method for the recombination of genetic elements |
| 06/03/2004 | WO2003072730A3 Secondary metabolite congener distribution modulation |
| 06/03/2004 | WO2003070972A3 RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/03/2004 | WO2003066894A3 Gene probes for the detection of the oenococcus species |
| 06/03/2004 | WO2003065012A3 Compositions and methods for reporting of protease activity within the secretory pathway |
| 06/03/2004 | WO2003064597A3 Aggrecanase molecules |
| 06/03/2004 | WO2003062415A3 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
| 06/03/2004 | WO2003057159A9 Psoriasin expression by breast epithelial cells |
| 06/03/2004 | WO2003054544A3 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 06/03/2004 | WO2003052107A9 Expression vector containing the promoter comprised of fis binding sites, up element and core promoter |
| 06/03/2004 | WO2003052056A3 Egviii endoglucanase and nucleic acids encoding the same |
| 06/03/2004 | WO2003041128A3 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
| 06/03/2004 | WO2003040292A3 Genes encoding for membrane synthesis and membrane transport proteins |
| 06/03/2004 | WO2003037930A8 Novel human n-methyl-d-asparatate (nmda) glutamate receptor polypeptide and gene encoding the same |
| 06/03/2004 | WO2003035894A8 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
| 06/03/2004 | WO2003020739A3 Novel lna compositions and uses thereof |
| 06/03/2004 | WO2003018820A3 Mutant recombinant adeno-associated viruses related applications |
| 06/03/2004 | WO2003016567A3 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 06/03/2004 | WO2003008587A8 A lactococcus gene, the amylolytic enzyme it encodes and its application |
| 06/03/2004 | WO2003006104A8 Lymphatic endothelial cells materials and methods |
| 06/03/2004 | WO2003000928A3 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 06/03/2004 | WO2002102846B1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/03/2004 | WO2002097108A3 Antisense modulation of dual specific phosphatase 5 expression |
| 06/03/2004 | WO2002078608A8 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 06/03/2004 | WO1997035010A8 Chemokine alpha 2 |
| 06/03/2004 | US20040107463 Transcription factor stress-related proteins and methods of use in plants |
| 06/03/2004 | US20040107462 Sucrose phosphate synthase |
| 06/03/2004 | US20040107461 for modification of biosynthesis pathways for production of new and improved starches; agriculture/horticulture; genetic engineering |
| 06/03/2004 | US20040107460 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 06/03/2004 | US20040107458 Gene encoding plant protein tm2a, conferring resistance to tomato mosaic virus |
| 06/03/2004 | US20040107457 Molecular mechanims for gene contaiment in plants |
| 06/03/2004 | US20040107456 Transcription factors for rice or barley cells used to produce antibodies; genetic engineering |
| 06/03/2004 | US20040107455 genetically enhancing the nutritional value/agronomic performance without permanent or stable incorporation of unknown/foreign DNA into plant genome |
| 06/03/2004 | US20040107454 to either enucleated oocytes which were matured in vivo or in vitro and activated or to enucleated zygotes; for production of transgenic animals, especially pigs; genetic engineering |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040107452 Gene targeting in animal cells using isogenic DNA constructs |
| 06/03/2004 | US20040106864 Method of predicting stroke evolution utilising mri |
| 06/03/2004 | US20040106784 Comprises nucleotide sequences coding negative regulators of cytokine signal transduction for use in screening modulators for treatment of diabetes, inflammation, metabolic and cancer disorders |
| 06/03/2004 | US20040106783 DNA fragments of the methylotrophic Pichia pastoris yeast ICL gene |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106777 Comprises nucleotide sequences coding extracelular matrix interacting protein for screening and identifying modulators and treatment for cancers and arteriosclerosis; tissue engineering |
| 06/03/2004 | US20040106728 Reagents and methods for solid phase synthesis and display |
| 06/03/2004 | US20040106570 down-regulate the expression of the RI alpha gene while producing fewer side effects than conventional oligonucleotides. In particular demonstrate reduced mitogenicity, reduced activation of complement and reduced antithrombotic properties |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |